v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
Previously Reported
Series Quantum Preferred Stock
Previously Reported
Common Stock
Previously Reported
Common Stock to be Issued
Previously Reported
Additional Paid-In Capital
Previously Reported
Non-Controlling Interest
Previously Reported
Accumulated Other Comprehensive Income
Previously Reported
Accumulated Deficit
Previously Reported
Series Quantum Preferred Stock
Common Stock
Common Stock to be Issued
Additional Paid-In Capital
Non-Controlling Interest
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Balances at Dec. 31, 2023                 $ 4,202 $ 30,948,057 $ (221,886) $ (31,062,852) $ (332,479)
Balances (in Shares) at Dec. 31, 2023                 42,017,948          
Sale of common stock                 $ 1,500 148,540 150,040
Sale of common stock (in Shares)                 15,000,000          
Issuance of common stock for liabilities                 $ 363 353,328 353,691
Issuance of common stock for liabilities (in Shares)                 3,631,354          
Common and preferred stock issued for cash                 $ 100 $ 505 1,014,350 1,014,955
Common and preferred stock issued for cash (in Shares)                 1,000,000 5,050,000          
Stock-based compensation                 $ 200 1,164,951 1,165,151
Stock-based compensation (in Shares)                 2,000,000          
Common stock to be issued pursuant to business combination                              
Net income (loss)                 (3,270,544) (3,270,544)
Balances at Dec. 31, 2024 $ 100 $ 6,770 $ 33,629,226 $ (221,886) $ (34,333,396) (919,186) $ 7,000 33,629,000 (222,000) (34,333,000) (919,000)
Balances (in Shares) at Dec. 31, 2024 1,000,000 67,699,302           1,000,000 67,699,302          
Stock-based compensation                 416,000 416,000
Stock-based compensation (in Shares)                          
Net income (loss)                 (660,000) (660,000)
Balances at Mar. 31, 2025                 $ 7,000 34,045,000 (222,000) (34,993,000) (1,163,000)
Balances (in Shares) at Mar. 31, 2025                 1,000,000 67,699,302          
Balances at Dec. 31, 2024 $ 100 $ 6,770 33,629,226 (221,886) (34,333,396) (919,186) $ 7,000 33,629,000 (222,000) (34,333,000) (919,000)
Balances (in Shares) at Dec. 31, 2024 1,000,000 67,699,302           1,000,000 67,699,302          
Net income (loss)                               (1,147,000)
Balances at Jun. 30, 2025                   $ 7,000 35,026,000 (222,000) (35,480,000) (669,000)
Balances (in Shares) at Jun. 30, 2025                   67,774,002            
Balances at Dec. 31, 2024 $ 100 $ 6,770 33,629,226 (221,886) (34,333,396) (919,186) $ 7,000 33,629,000 (222,000) (34,333,000) (919,000)
Balances (in Shares) at Dec. 31, 2024 1,000,000 67,699,302           1,000,000 67,699,302          
Settlement of related party liabilities                 $ (100) 675,800 675,700
Settlement of related party liabilities (in Shares)                 (1,000,000)          
Stock-based compensation                 1,077,319 1,077,319
Stock-based compensation (in Shares)                 214          
Common stock issued pursuant to business combination                 $ 800 12,879,200 12,880,000
Common stock issued pursuant to business combination (in Shares)                 8,000,000          
Common stock issued pursuant to private placement                 $ 149 1,834,821 1,834,970
Common stock issued pursuant to private placement (in Shares)                 1,494,700          
Common stock to be issued pursuant to business combination               3,407,250 $ 3,407,250 3,407,250
Common stock to be issued pursuant to business combination (in Shares)                 1,500,000          
Common stock issued pursuant to assets purchase agreement                 $ 900 19,709,100 19,710,000
Common stock issued pursuant to assets purchase agreement (in Shares)                 9,000,000          
Common stock issued pursuant to debt settlement                 $ 1 9,999 10,000
Common stock issued pursuant to debt settlement (in Shares)                 10,000          
Common stock issued pursuant to services                 $ 205 4,427,295 4,427,500
Common stock issued pursuant to services (in Shares)                 2,050,000          
Net income (loss)                 132,551 918,355 1,050,906
Balances at Dec. 31, 2025 $ 8,825 $ 3,407,250 74,242,760 (221,886) 132,551 (33,415,041) 44,154,459 $ 9,000 $ 3,407,000 74,243,000 (222,000) 133,000 (33,415,000) 44,155,000
Balances (in Shares) at Dec. 31, 2025 88,254,216 1,500,000           88,254,216 1,500,000          
Balances at Mar. 31, 2025                 $ 7,000 34,045,000 (222,000) (34,993,000) (1,163,000)
Balances (in Shares) at Mar. 31, 2025                 1,000,000 67,699,302          
Sale of common stock                   85,000 85,000
Sale of common stock (in Shares)                   74,700            
Settlement of related party liabilities                   676,000 676,000
Settlement of related party liabilities (in Shares)                 (1,000,000)              
Stock-based compensation                   220,000 220,000
Net income (loss)                   (487,000) (487,000)
Balances at Jun. 30, 2025                   $ 7,000 35,026,000 (222,000) (35,480,000) (669,000)
Balances (in Shares) at Jun. 30, 2025                   67,774,002            
Balances at Dec. 31, 2025 $ 8,825 $ 3,407,250 74,242,760 (221,886) 132,551 (33,415,041) 44,154,459 $ 9,000 $ 3,407,000 74,243,000 (222,000) 133,000 (33,415,000) 44,155,000
Balances (in Shares) at Dec. 31, 2025 88,254,216 1,500,000           88,254,216 1,500,000          
Stock-based compensation                 275,000 275,000
Stock-based compensation (in Shares)                          
Common stock issued pursuant to business combination                 $ (2,272,000) 2,272,000
Common stock issued pursuant to business combination (in Shares)                 1,000,000 (1,000,000)          
Common stock issued pursuant to private placement                 200,000 200,000
Common stock issued pursuant to private placement (in Shares)                 100,000          
Net income (loss)                 (87,000) (9,405,000) (9,492,000)
Balances at Mar. 31, 2026                 $ 9,000 $ 1,135,000 76,990,000 (222,000) 46,000 (42,820,000) 35,138,000
Balances (in Shares) at Mar. 31, 2026                 89,354,216 500,000          
Balances at Dec. 31, 2025 $ 8,825 $ 3,407,250 $ 74,242,760 $ (221,886) $ 132,551 $ (33,415,041) $ 44,154,459 $ 9,000 $ 3,407,000 74,243,000 (222,000) 133,000 (33,415,000) 44,155,000
Balances (in Shares) at Dec. 31, 2025 88,254,216 1,500,000           88,254,216 1,500,000          
Net income (loss)                               (2,113,000)
Balances at Jun. 30, 2026                 $ 10,000 $ 1,135,000 91,710,000 (222,000) 38,000 (35,433,000) 57,238,000
Balances (in Shares) at Jun. 30, 2026                 96,291,416 500,000          
Balances at Mar. 31, 2026                 $ 9,000 $ 1,135,000 76,990,000 (222,000) 46,000 (42,820,000) 35,138,000
Balances (in Shares) at Mar. 31, 2026                 89,354,216 500,000          
Stock-based compensation                       227,000 227,000
Common stock issued pursuant to business combination                   $ 1,000   14,473,000 14,474,000
Common stock issued pursuant to business combination (in Shares)                   6,924,700            
Common stock issued pursuant to private placement                 20,000 20,000
Common stock issued pursuant to private placement (in Shares)                   12,500            
Net income (loss)                           (8,000) 7,387,000 7,379,000
Balances at Jun. 30, 2026                 $ 10,000 $ 1,135,000 $ 91,710,000 $ (222,000) $ 38,000 $ (35,433,000) $ 57,238,000
Balances (in Shares) at Jun. 30, 2026                 96,291,416 500,000